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Acute adverse effects of air pollution on
asthma outcomes in small cohorts of children
have been reported in longitudinal studies
using repeated daily measurements (panel
studies). More recently, this includes positive
associations between a biomarker of airway
inﬂammation, exhaled nitric oxide, and both
personal and outdoor ambient air pollutant
exposures in children with asthma (Delfino
et al. 2006; Koenig et al. 2005). Most panel
studies of daily air pollution and acute
changes in expiratory lung function reported
before 2004 used measurements of peak expi-
ratory flow (PEF). They generally showed
consistent, albeit heterogeneous, inverse asso-
ciations of PEF with ambient particulate mat-
ter (PM) < 2.5 µm in diameter (PM2.5), with
somewhat weaker associations for PM
< 10 µm in diameter (PM10) [reviewed by
Ward and Ayers (2004)]. However, PEF is
more effort dependent than another measure
of lung function, forced expiratory volume in
1 sec (FEV1). PEF is also a poor surrogate of
the more clinically relevant FEV1 (Giannini
et al. 1997; Thiadens et al. 1999) because
PEF measures only the ﬁrst portion of expira-
tion from larger proximal airways, whereas
FEV1 reﬂects resistance in both proximal and
distal airways. Lower FEV1 occurs when ﬂow
rate decreases because of airway obstruction,
which is a key phenotype of asthma.
Most previous studies of the relationship
between acute asthma in children and air pol-
lution have relied on ambient central-site data
(Sarnat and Holguin 2007; Trasande and
Thurston 2005). Exposure error from using
this data will likely diminish the accuracy of
exposure–response estimates. High interpol-
lutant correlations at ambient monitoring
sites also make it difﬁcult to identify indepen-
dent associations from different regulated cri-
teria air pollutants such as PM2.5 and
nitrogen dioxide. Furthermore, criteria pollu-
tants may be serving as markers for compo-
nents not routinely monitored, such as
combustion-related organic compounds.
These component mixtures may lead to air-
way inflammation and bronchoconstriction.
However, a range of individual responses for
a given type of component exposure is likely
for children with asthma. Children at greatest
risk likely include those with persistent
asthma, particularly if they are not taking
controller medications. Personal exposure
assessments (Jerrett et al. 2005) and assess-
ments of clinical and biological differences in
an individual’s asthma (Sarnat and Holguin
2007) have been proposed to clarify these
issues regarding exposure and response. 
We previously found that associations of
asthma symptoms with ambient PM mass con-
centrations were completely explained by
ambient elemental and organic carbon frac-
tions of PM (EC and OC, respectively)
(Delfino et al. 2003). Studies have shown
much stronger correlations between traffic
emission sources and EC (or a similar measure
of black carbon reflectance) compared with
PM mass (Cyrys et al. 2003), but OC is more
difficult to apportion to emission sources
(Fujita et al. 2007). Our earlier ﬁnding thus
suggested that products of fossil fuel combus-
tion were important in asthma outcomes that
might otherwise be ascribed to uncharacterized
PM mass. Many studies have also shown
strong correlations between traffic emission
sources and NO2 (Jerrett et al. 2005). In
another panel study, we reported positive asso-
ciations between repeated measures of exhaled
NO and personal exposures to NO2 and EC
that were largely independent of associations
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BACKGROUND: Epidemiologic studies have shown associations between asthma outcomes and
outdoor air pollutants such as nitrogen dioxide and particulate matter mass < 2.5 µm in diameter
(PM2.5). Independent effects of speciﬁc pollutants have been difﬁcult to detect because most studies
have relied on highly correlated central-site measurements.
OBJECTIVES: This study was designed to evaluate the relationship of daily changes in percent-
predicted forced expiratory volume in 1 sec (FEV1) with personal and ambient air pollutant exposures.
METHODS: For 10 days each, we followed 53 subjects with asthma who were 9–18 years of age and
living in the Los Angeles, California, air basin. Subjects self-administered home spirometry in the
morning, afternoon, and evening. We measured personal hourly PM2.5 mass, 24-hr PM2.5 elemen-
tal and organic carbon (EC–OC), and 24-hr NO2, and the same 24-hr average outdoor central-site
(ambient) exposures. We analyzed data with transitional mixed models controlling for personal
temperature and humidity, and as-needed β2-agonist inhaler use.
RESULTS: FEV1 decrements were signiﬁcantly associated with increasing hourly peak and daily aver-
age personal PM2.5, but not ambient PM2.5. Personal NO2 was also inversely associated with FEV1.
Ambient NO2 was more weakly associated. We found stronger associations among 37 subjects not
taking controller bronchodilators as follows: Personal EC–OC was inversely associated with morn-
ing FEV1; for an interquartile increase of 71 µg/m3 1-hr maximum personal PM2.5, overall percent-
predicted FEV1 decreased by 1.32% [95% conﬁdence interval (CI), –2.00 to –0.65%]; and for an
interquartile increase of 16.8 ppb 2-day average personal NO2, overall percent-predicted FEV1
decreased by 2.45% (95% CI, –3.57 to –1.33%). Associations of both personal PM2.5 and NO2
with FEV1 remained when co-regressed, and both confounded ambient NO2.
CONCLUSIONS: Independent pollutant associations with lung function might be missed using ambi-
ent data alone. Different sets of causal components are suggested by independence of FEV1 associa-
tions with personal PM2.5 mass from associations with personal NO2.
KEY WORDS: asthma, epidemiology, forced expiratory ﬂow rates, longitudinal data analysis, nitro-
gen dioxide, panel study, particulate air pollution. Environ Health Perspect 116:550–558 (2008).
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2006). These ﬁndings suggested that in addi-
tion to products of fossil fuel combustion,
other particle components in personal air
samples were proinﬂammatory. Here we aim
to expand on these previous findings in the
same cohort of children by evaluating the
relationship of FEV1 to both personal and
central-site NO2, PM2.5 mass, and EC–OC
fractions of PM2.5.
Materials and Methods
Design and population. We followed a panel of
63 schoolchildren with asthma for daily
repeated measures of personal exposure to air
pollution in two regions of the Los Angeles air
basin in Southern California: Riverside and
Whittier. These regions are characterized by
high levels of air pollution predominantly from
mobile sources of fossil fuel combustion.
Geographic areas of recruitment were delim-
ited to a 10-mile radius around a central air
monitoring site in Riverside (population den-
sity, 3,538/mi2), and a 5-mile radius around a
central air monitoring site in Whittier
(5,947/mi2) (RAND California 2007). The
institutional review board of the University of
California, Irvine, approved the study protocol.
We obtained informed written consent from
all subjects and one of their legal guardians. 
We recruited subjects by referral to the
study office by local school district nurses.
Eligibility criteria included ages 9–18 years
and parent-reported physician-diagnosed
asthma, with a history of episodic symptoms
including wheezing, cough, or dyspnea. For
the cohort, we targeted children with evi-
dence of mild to moderate persistent asthma,
including a) a history in the previous 12
months of asthma exacerbations requiring the
use of prescribed bronchodilator(s) on ≥ 2
days per week, regardless of anti-inflamma-
tory medication use; b) current use of oral or
inhaled anti-inflammatory medications,
regardless of symptom frequency; or c) < 80%
predicted normal FEV1 from ofﬁce spirome-
try at the subject’s baseline visit to the
General Clinical Research Center, University
of California, Irvine. Subjects were ineligible
if they smoked or if someone smoked in the
subject’s home.
We followed subjects daily over a contin-
uous 10-day period that involved wearing air
samplers to measure personal exposure to air
pollutants. There were sixteen 10-day periods
of follow-up (a run) from July to December
2003 (Riverside) and 2004 (Whittier). Four
subjects were followed daily at their home in
each 10-day run (except one run with three
subjects).
Lung function and diary data. We have
presented spirometry methods and validation
results for the present panel subjects in detail
in our previous report (Thompson et al.
2006). Subjects self-administered spirometry
at home using the hand-held ndd EasyOne
Frontline Spirometer (ndd Technologies,
Chelmsford, MA). Subjects were given
detailed instructions and trained on its use in
the home during a 5-day run-in period.
Subjects were instructed to perform spirome-
try in the morning (up to 1100 hours), after-
noon (1500–1800 hours), and evening
(2000–2400 hours), referred to here as “ses-
sion period.” Subjects were also instructed to
complete a personal digital assistant (PDA)
diary every 2 waking hours reporting asthma
medication use. We mitigated missed PDA
diary prompts with paper diaries and daily
technician-administered questionnaires.
Medications reported included daily preven-
tive (controller) medications and as-needed
(rescue) medications (inhaled β2-agonist
bronchodilators). Near bedtime, the PDA
diary prompted recall of rescue and controller
medication use throughout the day. In the
morning, it prompted recall of rescue inhaler
use during the night. We also measured res-
cue inhaler use with a pressure-actuated
recording device (Doser; Meditrack Products,
Hudson, MA) that logged puffs in 24-hr
intervals from midnight to midnight.
During each session, the spirometer
stopped after three good spirometry maneu-
vers were obtained, and it gave each subject
up to six chances to meet acceptability and
repeatability criteria. Intermittent instructions
to subjects were displayed on the spirometer’s
display based on the success or type of error
of each attempt. Subjects were instructed to
perform sessions before the use of inhaled β2-
agonist bronchodilator medications unless
necessary, and to wait at least 4 hr after the
use of them before performing a session. At
the end of spirometry maneuvers, subjects
answered a yes/no question on the spirometer
screen: “Did you need to use your rescue
medication in the last hour?”
Research technicians downloaded the
spirometry data into laptops during daily home
visits, and checked compliance and acceptabil-
ity of maneuvers as generated by the ndd soft-
ware (version 2.6). We retrained subjects as
needed. Compliance was enhanced by mone-
tary incentives, an on-screen point system, and
audio alarms. We later evaluated each curve for
acceptability and repeatability by selected crite-
ria as previously described (Thompson et al.
2006). We then further evaluated these curves
for visual acceptability. We found compliance
was high (94%) and the number of sessions
with acceptable and reproducible maneuvers by
objective criteria as well as visually acceptable
was moderately good (69%) (Thompson et al.
2006). To ensure a suitably complete time
series of repeated measures, subjects included in
the present analysis had to have at least a third
of their 29 expected FEV1 maneuvers over the
10 days that were valid as such. We excluded
10 subjects who did not meet this compliance
threshold, leaving 53 subjects who had 1,249
observed of 1,537 expected spirometry sessions
(81%) with acceptable and reproducible
maneuvers (individual subject range, 41–100%,
median 86%).
The highest FEV1 (best effort) from the
two acceptable and reproducible maneuvers
was selected for analysis. We analyzed per-
cent-predicted normal FEV1 based on a sub-
ject’s height, age, sex, and race/ethnicity
(Hankinson et al. 1999). This standardizes
measurements between subjects, provides
overall estimates of association for the study
population, and is clinically meaningful. 
Exposures. The personal air monitors were
active air samplers worn in a backpack daily
over the 10 consecutive days. Personal meas-
urements included continuous nephelometer
mass measurements of PM2.5 (personal
DataRAM model 1200; MIE Inc., Bedford,
MA) and 24-hr EC and OC fractions of
PM2.5, collected on quartz filters (Whatman
Inc., Florham Park, NJ) using an attached ﬁl-
ter cassette. A 2.5-µm sharp-cut cyclone was
attached upstream of the nephelometer, and
PM2.5 for EC and OC was collected down-
stream at a flow rate of 4 L/min. We meas-
ured NO2 over 24-hr periods using a
miniaturized diaphragm pump (VMP1625;
Virtual Industry, Colorado Springs, CO) run
at 0.1 L/min to sample air through tri-
ethanolamine-treated molecular sieve sorbent
tubes (SKC West Inc., Fullerton, CA). We
measured NO2 based on National Institute
for Occupational Safety and Health (1994)
Method 6014. We collected personal temper-
ature and relative humidity with attached log-
gers (Onset Computer Corp., Pocasset, MA).
Elsewhere we provide data on the validation
of both the personal PM2.5 sampler
(Chakrabarti et al. 2004) and our personal
NO2 active sampler (Staimer et al. 2005).
We measured a parallel set of exposures at
our own outdoor central sites, one in
Riverside and one in Whittier. PM2.5 and
PM10 mass (Teflon filters), and PM2.5 EC
and OC (quartz filters) were collected there
using standard procedures with Harvard
Impactors (Air Diagnostics and Engineering,
Inc., Naples, ME). Sampling start and stop
times occurred during the early evening of
each day near the same time as personal sam-
plers. For both personal and central-site sam-
ple collection on quartz filters, particulate
carbon was speciated into OC and EC using
the thermal manganese dioxide oxidation
technique (Fung et al. 2002). Central-site
gases included hourly ozone and NO2 meas-
ured by the South Coast Air Quality
Management District. In Riverside, the dis-
trict site was centrally located, and we sited
Harvard Impactors there. In Whittier, we
Air pollution and FEV1 in children with asthma
Environmental Health Perspectives • VOLUME 116 | NUMBER 4 | April 2008 551constructed a central site at a subject home
elevated on a hill. However, data for O3 and
NO2 came from two district sites at opposite
ends of the Whittier study region. We aver-
aged hourly concentrations of these gases for
the two stations.
Analysis. We tested the relationship
between percent-predicted FEV1 and each air
pollutant using linear mixed-effects models,
with each subject serving as his or her own
control (Verbeke and Molenberghs 2001).
Because correlation among outcomes was pre-
sent for the within-individual repeated meas-
ures, and possibly for the exposure run, we
assumed a two-stage hierarchical model with
random effects at the subject level, nested
within a run. We ﬁt an autoregressive-1 corre-
lation structure given the observed variability
from empirical variograms. Air pollutant
exposures were mean-centered by subject to
yield comparability between subjects and
across runs (Sheppard et al. 2005).
We investigated impacts of personal
hourly PM2.5 mass exposures preceding the
FEV1 measurement including the average of
the preceding 24 hr (lag 0), the average of the
25th through 48th hr (lag 1), and a cumula-
tive 2-day moving average. We retained
PM2.5 data if at least 75% of the hours were
nonmissing. The same approach was used for
central-site hourly NO2. Given our previous
ﬁndings (Delﬁno et al. 1998, 2002), we also
examined 1-hr and 8-hr maximum moving
average in personal PM2.5 during the 24 hr
preceding the FEV1 measurement. We exam-
ined 8-hr peak central-site O3 given its well-
known diurnal trend. For the filter-based
measurements (personal and central-site EC
and OC, and central-site PM2.5 mass) and for
personal NO2, we defined lag 0 to be the
same day and lag 1 was the preceding day’s
24-hr measurement. We did not extend the
number of lags beyond that last 2 days to
maintain a reasonable within-subject sample
size, because a subject’s data were limited to a
single 10-day consecutive monitoring period.
We expressed results as percent change in pre-
dicted FEV1 per interquartile range (IQR)
increase in each pollutant to standardize inter-
pollutant comparisons.
We fit transitional models by adjusting
for the previous FEV1 measurement to con-
trol for observed sinusoidal circadian
rhythms. Transitional models condition the
outcome in the current time on the previous
outcome observation (e.g., afternoon FEV1 is
regressed on the morning FEV1) (Diggle et al.
2002). We also tested for effect modiﬁcation
by session period (morning, afternoon,
evening), and found several differences that
we present below.
We decided a priori to adjust for use of
rescue inhalers, including use last night, which
was associated with a decrease of 3.5 percent-
predicted FEV1 in the afternoon and evening
[95% conﬁdence interval (CI), –6.5 to –0.4].
We also included cumulative daily use of res-
cue inhalers during the previous day using
Doser data [PDA diary data for 119 person-
days were used where Doser data were missing
(9.5%)]. Cumulative inhaler use was positively
associated with an increase of 1.1 percent-pre-
dicted FEV1 in the morning per two-puff dose
(95% CI, –0.2 to 2.5). In addition, we
excluded observations where subjects reported
use of rescue inhalers in either the ndd
spirometer diary or PDA diary report covering
the last 2–4 hr (57 FEV1 observations, 4.6%
of total). Such use was associated with an
increase of 2.2 percent-predicted FEV1 (95%
CI, 0.07 to 4.3). Models also adjusted for per-
sonal temperature and relative humidity (both
positively associated with FEV1).
We tested potential confounding by self-
reported respiratory infections (22 person-
days, 4.4% of total, p = 0.86 in relation to
FEV1). We also tested confounding by the
two regions of study, session period of day
(morning, afternoon, or evening), and week-
end. None of these variables inﬂuenced asso-
ciations, with one exception discussed below
for session period. 
We conducted residual diagnostics to
assess the presence of influential data points
and subject clusters, as well as deviations from
assumed functional form. One 10-year-old
white female subject inﬂuenced personal PM
models leading to a decrease in personal PM2.5
regression parameter estimates and increase in
SE (Cook’s D, 0.38; restricted likelihood dis-
tance, 4.41). We present results with this sub-
ject and sensitivity analyses removing her data.
Given prior evidence (Becklake and
Kauffman 1999; Delfino et al. 1998, 2002,
2006), we further tested models for effect
modiﬁcation by sex and by asthma controller
medications using product terms with each
air pollutant. We assumed product term
interactions with a p-value < 0.1 suggested
possible effect modification. We tested a
binary (yes/no) indicator for use of anti-
inﬂammatory medications, as well as separate
indicators for inhaled corticosteroids with ver-
sus without leukotriene receptor antagonists.
We also tested a binary indicator for pre-
scribed daily use of short- or long-acting
bronchodilators as controller medications.
We anticipated both controller and rescue
bronchodilators to have major impacts on
temporal changes in FEV1.
We tested two-pollutant regression mod-
els to assess between-pollutant confounding
after testing interaction between the pollu-
tants in product term models. The aim here
was to assess the extent to which associations
with one pollutant was independent of
another pollutant.
We retested selected regression models
using generalized estimating equations with
robust standard error estimates (Diggle et al.
2002) as a validity check to likelihood
assumptions of the linear mixed-effects
model. We found no qualitative differences in
our study results.
Finally, we used a ﬁfth-order polynomial
distributed-lag mixed-effects model (Schwartz
2000) to investigate the relationship of FEV1
to lagged hourly personal PM2.5 exposures out
Delfino et al.
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Table 2. Differences in subject FEV1 by time of day and medication use.
Percent-predicted FEV1
a Mean ± SD Median Range 
Overall (53 subjects) 86.8 ± 15.9 89.4 30–126
Morning 84.7 ± 17.0 88.0 33–116
Afternoon 88.6 ± 15.0 90.5 40–123
Evening 87.5 ± 15.7 89.2 30–126
Differences by medication use
No controller medications (20 subjects) 86.3 ± 16.5 89.1 41–119
Inhaled corticosteroids (27 subjects)b 88.0 ± 14.4* 89.0 44–126
Antileukotrienes ±
inhaled corticosteroids (13 subjects)c 85.2 ± 16.8* 89.2 30–126
Controller bronchodilators (16 subjects)d 86.1 ± 15.7 87.1 44–116
aPredicted from NHANES III (Hankinson et al. 1999) and based on data from the panel follow-up used in the present analy-
sis. bOne subject was also using inhaled cromolyn. cFour subjects were using antileukotrienes only, and nine were using
antileukotrienes plus inhaled corticosteroids. dFive subjects were using daily short-acting β2-agonist medications, two of
whom were also using an anticholinergic medication (ipratropium bromide), 11 were using long-acting bronchodilator
medications (sustained release theophylline and the long-acting β2-agonist, salmeterol xinafoate), and 14 were also using
anti-inﬂammatory medications. *Random-effects model p < 0.05 for predicted FEV1 difference from subjects not on con-
troller medications, adjusted for study region.
Table 1. Study group characteristics.
Characteristic Data
Age [years, mean (range)] 13.8 (9–18)
Sex [no. (%)]
Female 19 (35.9)
Male 34 (64.1)
Race/ethnicity no. (%)
Hispanica 26 (49.1)
White 12  (22.6)
Black 13  (24.5)
Asian 2 (3.8)
No. (%) with percent- 18 (34.0)
predicted FEV1 < 80%b
aIncludes 20 Hispanic subjects who gave no race and
6 who gave their race as white; two blacks and 
2 Asians also gave their ethnicity as Hispanic. bPredicted
from the Third National Health and Nutrition Examination
Survey (NHANES III) (Hankinson et al. 1999) from baseline
spirometry. to 48 hr. We found negligible difference in the
response curves when models that are more
ﬂexible were considered. We ﬁt distributed lag
models via a linear mixed-effects model assum-
ing an autoregressive-1 correlation structure.
Results
Descriptive data. Descriptive statistics for the
53 subjects in the present analysis are pre-
sented in Table 1. On average, FEV1 was low-
est in the morning and gradually increased to
its highest in the afternoon, then decreased
toward the evening (Table 2). We found per-
cent-predicted FEV1 was signiﬁcantly higher
among 28 subjects taking inhaled corticos-
teroids, and signiﬁcantly lower among 13 sub-
jects taking antileukotrienes compared with 20
subjects not taking controller medications
(Table 2). There was no signiﬁcant difference
in FEV1 for 16 subjects taking controller
bronchodilators versus those not taking them.
We collected 519 person-days of valid
observations for the personal NO2 air moni-
tor. It malfunctioned for only 3 person-days.
The PM2.5 nephelometer malfunctioned for
two subjects during most of their 10-day run
and periodically for other subjects, leaving
416 person-days of observation. Table 3 pre-
sents descriptive statistics for the exposure
data. Concentrations of peak hourly personal
PM2.5 were high, averaging 90 µg/m3 with a
maximum reaching 603 µg/m3. The U.S.
Environmental Protection Agency National
Ambient Air Quality Standard (NAAQS) for
8-hr ambient O3 (80 ppb) was never exceeded
(U.S. Environmental Protection Agency
2008). However, the NAAQS for 24-hr aver-
age ambient PM2.5 (35 µg/m3) was exceeded
on 28 of 170 days and NAAQS for 24-hr
average ambient PM10 (150 µg/m3) was
exceeded on only 1 day at the central sites.
Figure 1 shows hourly average concentra-
tions of personal PM2.5. Concentrations were
lowest in the early morning, abruptly rising
mid-morning with maximums around noon
and sustained concentrations until late
evening. The mid-morning peak occurred
around 0800 hr during the school weekday
but was delayed by several hours and was
higher on weekends. 
Table 4 shows the between-pollutant cor-
relations. Small signiﬁcant correlations of per-
sonal PM2.5 with personal EC, OC, and NO2
were found. Personal PM2.5 was moderately
correlated with ambient PM2.5 (Spearman r =
0.60), and had small correlations with per-
sonal NO2 (r = 0.38) and ambient NO2 (r =
0.32). Personal NO2 showed low moderate
correlation with ambient NO2 (Spearman r =
0.43). However, personal EC and OC were
not correlated with ambient EC and OC but
were weakly correlated with ambient NO2.
Ambient exposures were moderately cor-
related with each other. 
Regression analysis. Table 5 shows models
for the relationship between percent-predicted
FEV1 and air pollutants. We found signiﬁcant
inverse associations between FEV1 and 1-hr
and 8-hr peak personal PM2.5 measured over
the 24-hr periods preceding the lung function
measurements (lag 0). The model for lag 0
24-hr average personal PM2.5 showed smaller
associations for an interquartile increase in
exposure, and was of borderline significance
(p < 0.08). However, dropping the one inﬂu-
ential subject discussed in “Methods” led to a
stronger significant association with 24-hr
personal PM2.5 (–0.69% predicted FEV1;
95% CI, –1.34 to –0.04%). Outdoor central-
site 24-hr average PM2.5 (Table 5) and PM10
(not shown) were not associated with FEV1.
Neither personal nor central-site EC or OC
was associated with FEV1. Personal NO2 expo-
sures were significantly inversely associated
with FEV1, at lag 0 day and almost signiﬁcant
at lag 1 day (p = 0.06). This association was
stronger with a 2-day moving average of lag 0
+ 1 personal NO2 (not shown; –1.75%; 95%
CI, –2.83 to –0.673%). Central-site NO2 was
more weakly but signiﬁcantly associated with
FEV1 deficits at lag 0, but not at lag 1 day.
Although regression coefﬁcients were negative,
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Table 3. Descriptive statistics of daily air pollutant measurements. 
Exposure No. (missing) Mean ± SD Median IQR Min/max
Personal exposurea
1-hr max PM2.5 (µg/m3) 416 (154) 90.1 ± 79.8 66.2 70.6 14.1/603.4
8-hr max PM2.5 (µg/m3) 416 (154) 46.2 ± 33.4 36.8 33.6 7.5/240.8
24-hr PM2.5 (µg/m3) 416 (154) 31.2 ± 21.8 26.0 21.6 4.3/180.0
24-hr PM2.5 EC (µg/m3) 481 (89) 0.59 ± 1.11 0.33 0.54 0/17.2
24-hr PM2.5 OC (µg/m3) 486 (84) 6.0 ± 3.4 5.2 4.3 1.0/31.5
24-hr NO2 (ppb) 519 (51) 28.6 ± 13.2 26.7 16.8 2.8/105.7
24-hr temperature (°C) 516 (54) 24.8 ± 3.0 25.4 4.2 17.3/32.1
Central site PM (µg/m3)b
24-hr PM2.5 170 (4) 23.3 ± 17.7 17.1 15.6 2.8/87.2
24-hr PM10 170 (4) 45.9 ± 26.3 39.1 23.7 5.9/154.0
24-hr PM2.5 EC 167 (7) 1.12 ± 0.77 0.97 0.90 0.14/5.04
24-hr PM2.5 OC 167 (7) 5.0 ± 2.4 4.7 2.8 1.5/19.7
Central site gases (ppb)c
8-hr max O3 174 (0) 50.7 ± 16.2 49.1 35.7 32.5/77.6
24-hr NO2 174 (0) 25.0 ± 3.0 25.3 6.3 19.9/29.2
Abbreviations: min, minimum; max, maximum.
aPerson-days of observation, usually four personal exposure measurements per day. bSingle days of observation, which
would each be linked to all four subjects followed that day. cAround 4–5% of total hours on days with ≤ 5 contiguous
hours missing were interpolated using a kernel smoother (running weighted average), including the daily calibration hour.
In Riverside, 20 days with 6–24 hr of NO2 missing (15.3% of total days) and 1 day with 6 hr for O3 (0.8% of total days) were
interpolated using prediction equations based on data from the nearby Rubidoux, California, station (8 km). In Whittier, 3
days with 7–24 hr of NO2 missing (2.4% of total days) and 1 day with 7 hr for O3 (0.8% of total days) were interpolated by
linear regression equations based on data from the other nonmissing station data and used to estimate average regional
exposure across the two stations. 
Figure 1. Hourly average concentration of personal PM2.5 across 51 subjects for all days, weekdays, and
weekends.
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Weekendscentral-site O3 was not signiﬁcantly associated
with FEV1.
There was no difference in FEV1 associa-
tions between sexes in models including a
product term of sex by air pollutant. There
were also no signiﬁcant interactions between
use of anti-inﬂammatory medications and air
pollutants. However, we did ﬁnd signiﬁcantly
weaker associations among 16 children taking
daily bronchodilator controller medications
compared with those not taking these med-
ications. Table 6 shows models for the rela-
tionship between percent-predicted FEV1 and
lag 0 day air pollutants stratified by use of
bronchodilator controller medications.
Associations for personal NO2 and PM2.5 and
ambient NO2 largely reflect those found
among all subjects (Table 5), but are stronger
in the 37 subjects not taking controller bron-
chodilators, including 24-hr average personal
PM2.5. For an interquartile increase of
16.8 ppb 2-day average personal NO2, (not
shown) percent-predicted FEV1 decreased by
–2.45% (95% CI, –3.57 to –1.33%) in sub-
jects not taking controller bronchodilators,
but there was no association in subjects taking
controller bronchodilators (p = 0.74). 
To assess the potential importance of
indoor NO2 sources, we retested NO2 models
by including the presence of gas stoves as a
binary variable, and a trinomial variable to
account for gas stoves with or without pilot
lights. Concentrations of personal NO2 were
significantly higher for 22 subjects with gas
stoves having pilot lights than for 12 subjects
without gas stoves (mean = 32.4 ppb vs.
25.0 ppb, respectively), and higher than for
19 subjects with gas stoves but no pilot lights
(mean = 26.4 ppb). However, gas stove covari-
ates in the mixed models did not affect the
magnitude or statistical signiﬁcance of associa-
tions of FEV1 with personal NO2. In addition,
stratiﬁed analyses by gas stoves did not reveal
signiﬁcant differences in associations between
FEV1 with NO2 (p > 0.6). These ﬁndings held
when stratiﬁed by bronchodilator group.
Figure 2 shows single-pollutant compared
with two-pollutant models including subjects
with both personal PM2.5 and NO2 data, and
excluding the influential subject. Significant
associations for 2-day average personal NO2
and lag 0 1-hr maximum PM2.5 remained
when regressed together in the same model,
with small decreases in estimates of associa-
tion. A two-pollutant model with lag 0 24-hr
averages of both personal NO2 and PM2.5 was
consistent with these findings (not shown).
Models testing product terms between per-
sonal NO2 and PM2.5 on FEV1 showed no
evidence of interaction.
We also tested two-pollutant models for
24-hr average personal NO2 and ambient
NO2, and for 24-hr average personal PM2.5
and ambient NO2, excluding the influential
subject. Figure 3 shows that personal NO2 led
to a halving of the estimated FEV1 regression
coefﬁcient for ambient NO2, whereas personal
NO2 is reduced by 20% in the two-pollutant
model. Similarly, personal PM2.5 led to a 43%
reduction in the estimated regression coeffi-
cient for ambient NO2 whereas the personal
PM2.5 coefficient is reduced by 18% in the
Delfino et al.
554 VOLUME 116 | NUMBER 4 | April 2008 • Environmental Health Perspectives
Table 4. Exposure correlation matrix.
Personal Central site
PM2.5 EC OC NO2 PM2.5 EC OC NO2
24-hr personal PM2.5 1.00 0.22** 0.26** 0.38** 0.60** 0.14* 0.24** 0.32**
24-hr personal EC 1.00 0.44** 0.22** 0.02 –0.01 0.00 0.20**
24-hr personal OC 1.00 0.20** –0.04 –0.08 0.01 0.16**
24-hr personal NO2 1.00 0.21** 0.20** 0.18** 0.43**
24-hr central PM2.5 1.00 0.51** 0.62** 0.36**
24-hr central EC 1.00 0.84** 0.61**
24-hr central OC 1.00 0.56**
24-hr central NO2 1.00
*p < 0.05, and **p < 0.001, from Wald-based tests of Spearman correlation coefﬁcients. 
Table 5. Mixed-model estimates of the association between personal and central-site air pollutant expo-
sures and percent-predicted FEV1 in 53 schoolchildren with asthma.
Personal Central site
Exposure Coefﬁcienta (95% CI) p-Value Coefﬁcient (95% CI) p-Value
PM2.5 1-hr maximum
Lag 0 –0.969 (–1.538 to –0.399) 0.001 NA
Lag 1 0.073 (–0.595 to 0.740) 0.831 NA
PM2.5 8-hr maximum
Lag 0 –0.801 (–1.465 to –0.137) 0.018 NA
Lag 1 0.107 (–0.584 to 0.798) 0.761 NA
PM2.5 24-hr average
Lag 0 –0.592 (–1.251 to 0.068) 0.079 –0.004 (–0.650 to 0.642) 0.990
Lag 1 0.049 (–0.613 to 0.711) 0.885 –0.142 (–0.775 to 0.491) 0.660
PM2.5 EC 24-hr average
Lag 0 –0.080 (–0.397 to 0.238) 0.623 –0.184 (–1.038 to 0.671) 0.673
Lag 1 0.067 (–0.467 to 0.602) 0.805 –0.129 (–0.970 to 0.712) 0.763
PM2.5 OC 24-hr average
Lag 0 –0.278 (–1.222 to 0.666) 0.564 –0.402 (–1.361 to 0.557) 0.411
Lag 1 –0.368 (–1.548 to 0.812) 0.540 –0.188 (–1.169 to 0.793) 0.707
NO2 24-hr average
Lag 0 –1.217 (–1.958 to –0.476) 0.001 –0.408 (–0.768 to –0.047) 0.027
Lag 1 –0.713 (–1.456 to 0.030) 0.060 –0.062 (–0.394 to 0.269) 0.712
O3 8-hr maximum
Lag 0 NA –0.383 (–1.752 to 0.986) 0.583
Lag 1 NA –0.904 (–2.314 to 0.506) 0.209
NA, not available. Lag 0: most recent 24-hr average measurement preceding the FEV1 measurement; lag 1: previous 24-hr
average measurement preceding the FEV1 measurement. 
aCoefficients represent the expected change in FEV1 associated with one IQR change in each air pollutant level (see
Table 2), adjusted for the previous FEV1 measurement, personal temperature, personal relative humidity, cumulative
inhaler use on the previous day, and inhaler use during the last night, and excluding observations where there was use of
inhaled as-needed bronchodilators in the preceding 4 hr.
Table 6. Mixed-model estimates of associations between percent-predicted FEV1 and lag 0 air pollutant
exposures stratiﬁed by preventive bronchodilator medication use.
Not taking bronchodilator Taking bronchodilator
controller medications (37 subjects) controller medications (16 subjects)
Exposure Coefﬁcienta (95% CI) p-Value Coefﬁcient (95% CI) p-Value
Personal
PM2.5 1-hr maximum –1.324 (–2.001 to –0.648) 0.0001 –0.145 (–1.230 to 0.940) 0.792
PM2.5 24-hr average –0.785 (–1.526 to –0.043) 0.038 0.004 (–1.478 to 1.486) 0.996
PM2.5 EC –0.249 (–1.022 to 0.524) 0.527 –0.075 (–0.442 to 0.293) 0.689
PM2.5 OC –0.577 (–1.636 to 0.482) 0.285 0.441 (–1.678 to 2.561) 0.682
NO2 –1.443 (–2.257 to –0.629) 0.001 –0.587 (–2.432 to 1.257) 0.531
Central site
PM2.5 –0.003 (–0.719 to 0.712) 0.992 –0.101 (–1.745 to 1.544) 0.904
PM2.5 EC –0.616 (–1.659 to 0.428) 0.247 0.733 (–0.921 to 2.387) 0.383
PM2.5 OC –0.503 (–1.666 to 0.660) 0.396 –0.329 (–2.198 to 1.540) 0.729
NO2 –0.555 (–0.966 to –0.143) 0.008 –0.048 (–0.859 to 0.764) 0.908
Lag 0: most recent 24-hr average measurement preceding the FEV1 measurement.
aCoefficients represent the expected change in FEV1 associated with one IQR change in each air pollutant level (see
Table 2), adjusted for the previous FEV1 measurement, personal temperature, personal relative humidity, cumulative
inhaler use on the previous day, and inhaler use during the last night, and excluding observations where there was use of
inhaled as-needed bronchodilators in the preceding 4 hr. two-pollutant model. Models with maximum
personal PM2.5 were consistent with these ﬁnd-
ings (not shown). An enhancement of FEV1
deﬁcits was observed with a product term of
personal NO2 with ambient NO2 (p < 0.06).
Figure 4A shows a distributed lag model
across 48 hr of personal PM2.5 data including
all 51 subjects with data. Inverse associations
are shown between personal PM2.5 at the 9th
through 18th hr preceding FEV1 measurements
(FEV1 association with 9th through 18th-hr
average, –0.73%; 95% CI, –1.25 to –0.22%).
After 24 hr, CIs cross zero and there is evidence
of a repeating 24-hr pattern across the 2 days.
An unexpected positive association is shown in
the 5 hr preceding FEV1 measurements (FEV1
association with 0- through 5th-hr average,
0.34%; 95% CI, –0.13 to 0.81). The 0-
through 5th-hr average was confounded to
–0.19% by adding an indicator for session
period (morning, afternoon, or evening). This
ﬁnding is attributable to morning FEV1 when
both lung function (Table 2) and personal
PM2.5 (Figure 1) were lowest, as expected.
Thus, the positive association was temporally
confounded. In contrast, the session period
indicator did not confound the inverse associa-
tion for the average of the 9th- through 18th-hr
PM2.5 preceding FEV1. Figure 4B adjusts for
session period. Figure 5A–C shows the distrib-
uted lag effects by session period in the group
not taking bronchodilators (a similar but
slightly less signiﬁcant pattern was found using
all subjects). Figure 5A shows that lags from
the previous day (9th–18th hr) adversely
affected morning FEV1 in particular. This lag
effect then shifted back in time for the after-
noon (Figure 5B) and evening FEV1 (Figure
5C) to approximately the same exposures on
the previous day. 
These results suggested that effects might
differ by session period. Therefore, we tested
product term models for session period by
each pollutant. Few meaningful product
terms were found at p < 0.1. Personal 1-hr
maximum PM2.5 associations were stronger
for the afternoon (–1.91%, p < 0.0001) than
for the morning (–0.85%, p < 0.08) or
evening FEV1 (–0.42%, p < 0.29). In subjects
not using bronchodilators, the coefﬁcient for
personal OC was signiﬁcantly more negative
for afternoon FEV1 (–1.47%, p < 0.05) and
morning FEV1 (–1.53%, p < 0.1) than for
evening FEV1 (1.46%, p < 0.1). The coeffi-
cient for personal EC was also significantly
different for morning FEV1 (–1.11%,
p < 0.08). In addition, the coefficient for
ambient NO2 lag 0 was significantly more
negative for the morning FEV1 (–1.16%,
p < 0.0005) than other FEV1 (p = 0.5).
Discussion
We found that increased personal exposures to
NO2 and PM2.5 were associated with lung func-
tion deﬁcits in schoolchildren with persistent
asthma. To our knowledge, this is the first
report of associations between personal exposure
to daily NO2 and FEV1 decrements in children
with asthma. The largest magnitude of associa-
tion was a 2.45% drop of percent-predicted
FEV1 for a small interquartile increase of 16.8
ppb 2-day average NO2 in 37 subjects not tak-
ing controller bronchodilators. We found con-
sistent but weaker associations for ambient NO2
measured at central regional sites. However, we
found no associations of FEV1 with ambient
PM, likely because of exposure error and the
short sampling period of 10 days per subject.
In two-pollutant models for personal
NO2 and PM2.5, we showed considerable
independence of associations with FEV1 sug-
gesting that personal PM2.5 mass represents
different causal components than personal
NO2. This may have at least partly resulted
from the different averaging times for each of
the pollutants because NO2 was sampled over
ﬁxed 24-hr intervals, whereas PM2.5 was meas-
ured continuously and linked to thrice daily
FEV1 by real time. We previously reported
consistent independent associations of exhaled
NO (measured once daily) with personal
PM2.5 and NO2 averaged across the same
24-hr intervals in 45 of the subjects in the pre-
sent analysis (Delﬁno et al. 2006). In addition
to products of fossil fuel combustion, personal
PM2.5 mass may also represent a variety of
other exposures, including bioaerosols such as
endotoxin that can exacerbate asthma. Our
data also suggest that personal PM2.5 reﬂects
ambient PM2.5, given the moderate correlation
between them (r = 0.60).
Because of the presumed superiority of
personal exposures in assessments of exposure–
response relationships, we anticipated that
associations for personal exposures would con-
found associations for ambient exposures.
Furthermore, Sarnat et al. (2005) found that
ambient NO2 concentration was a good surro-
gate of personal PM2.5 exposure. This suggests
that epidemiologic ﬁndings for ambient NO2
may be attributable to personal PM exposures.
We confirmed and expanded these expecta-
tions by ﬁnding that both personal NO2 and
personal PM2.5 confounded associations of
FEV1 with ambient NO2. Because personal
PM2.5 and personal NO2 had largely indepen-
dent effects and both confounded ambient
NO2, they may represent both similar and dif-
ferent information about causal components.
The interaction between personal and ambient
Air pollution and FEV1 in children with asthma
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Figure 2. Adjusted single- and two-pollutant models (coefﬁcient and 95% CIs)
for change in FEV1 in relation to personal 1-hr maximum PM2.5 the last 24 hr,
and 2-day average NO2 measurements. Expected change in FEV1 corresponds
to an IQR change in the air pollutant (Table 2), and estimates are plotted by
open symbols for single-pollutant models and solid symbols for models adjust-
ing for the indicated co-pollutant. Single-pollutant models are for the subset of
nonmissing observations for the other co-pollutant, and thus exclude two sub-
jects who did not have personal PM2.5 data. 
–5 –4
Expected change in percent-predicted FEV1
–3 –2 –1 0 1
PM2.5 alone
PM2.5 with NO2
NO2 alone
NO2 with PM2.5
PM2.5 alone
PM2.5 with NO2
NO2 alone
NO2 with PM2.5
–0.99 ± 0.32
–0.85 ± 0.32
–1.41 ± 0.64
–1.07 ± 0.64
–1.41 ± 0.38
–1.20 ± 0.38
–2.16 ± 0.70
–1.76 ± 0.68
Subjects not using bronchodilators (n = 37)
All subjects (n = 51)
Figure 3. Adjusted single- and two-pollutant models (coefﬁcient and 95% CIs)
for change in FEV1 in relation to lag day 0 personal 24-hr average NO2 (pNO2)
or PM2.5 (pPM2.5), with ambient 24-hr average NO2 (aNO2). Expected change in
FEV1 corresponds to an IQR change in the air pollutant (Table 2), and estimates
are plotted by open symbols for single-pollutant models and solid symbols for
models adjusting for the indicated co-pollutant. Single-pollutant models are for
the subset of nonmissing observations for the other co-pollutant in 51 subjects
with pPM2.5 data. 
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–0.55 ± 0.20
–1.11 ± 0.48NO2 further support this. In a previous panel
study of children with asthma in Southern
California, we also found that FEV1 was
inversely associated with ambient NO2, but
this was completely confounded by personal
PM (Delﬁno et al. 2004). These ﬁndings sug-
gest that personal PM2.5 and NO2 represent
some set of causal background air pollutants
also represented by ambient NO2. What pol-
lutant components and sources are driving
associations, though? 
Outdoor NO2 is strongly influenced by
local traffic density (Jerrett et al. 2005).
Although indoor sources such as gas stoves
contribute to personal exposure as well (Levy
et al. 1998), we found that presence of gas
stoves did not explain the association of FEV1
with personal NO2. In a large study of 482
homes in Los Angeles, outdoor home NO2
was well correlated with personal NO2 (R2 =
0.52) because of indoor inﬁltration (Spengler
et al. 1994). Traffic-related sources of NO2
contribute to high spatial variability of poten-
tially important particulate and gaseous co-
pollutants (Sioutas et al. 2005). There is
considerable evidence that such variability is
best captured by personal exposure measure-
ments (Jerrett et al. 2005). This is important
among children who may be exposed at
home, at school, and at other locations
including times in vehicles. The correlation
between personal and ambient NO2 (r =
0.43) as well as the confounding of the ambi-
ent NO2 association by personal NO2 are
consistent with the view that in addition to
local trafﬁc sources, some part of the associa-
tion we found between personal NO2 and
FEV1 was attributable to ambient back-
ground sources of NO2. The statistical inter-
action between personal NO2 with ambient
NO2 may reﬂect this source difference.
Plausible mechanisms of NO2 toxicity
have been well described (Persinger et al.
2002) and may contribute to part of our ﬁnd-
ings. However, in experimental exposure
studies of adults with mild asthma, adverse
pulmonary effects of NO2 have generally
been demonstrated at levels of exposure a
Delfino et al.
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Figure 4. Estimated lag effect of hourly personal PM2.5 on FEV1 in the full cohort of 51 subjects. (A) Not
adjusted for maneuver; (B) adjusted for maneuver. Estimates are based on a 5th-degree linear mixed-
effects polynomial distributed lag model with AR(1) correlation structure. Expected change in FEV1 for
each hour corresponds to an IQR change (21.6 µg/m3) in 24-hr average PM2.5 and estimates are plotted by
solid circles. Pointwise 95% CIs are plotted by error bars. All estimates are adjusted for the previous FEV1
measurement, personal temperature, personal relative humidity, cumulative inhaler use on the previous
day, and inhaler use during the last night, and excluding observations where there was use of inhaled as-
needed bronchodilators in the preceding 4 hr.
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Figure 5. Estimated lag effect of hourly personal PM2.5 on FEV1 by session period in 37 subjects with no controller bronchodilator use. (A) morning; (B) afternoon;
and (C) evening. Estimates are based on a 5th-degree linear mixed-effects polynomial distributed lag model with AR(1) correlation structure. Expected change in
FEV1 for each hour corresponds to an IQR change (21.6 µg/m3) in 24-hr average PM2.5, and estimates are plotted by solid circles. Pointwise 95% CIs are plotted by
error bars. All estimates are adjusted for the previous FEV1 measurement, personal temperature, personal relative humidity, cumulative inhaler use on the previ-
ous day, and inhaler use during the last night, and excluding observations where there was use of inhaled as-needed bronchodilators in the preceding 4 hr.
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1magnitude higher than reported here (Kraft
et al. 2005). These experimental results con-
trast recent epidemiologic findings showing
associations of asthma outcomes in children
with low levels of indoor NO2 (Belanger et al.
2006), of weeklong personal NO2 (Chauhan
et al. 2003), and of ambient NO2 (Kim et al.
2004; Schildcrout et al. 2006). We believe the
low personal NO2 levels we found are more
likely to have served as a surrogate for trafﬁc-
related air pollutants. These pollutants may
be causally related to asthmatic responses
through oxidative stress responses induced by
pollutants highly correlated with NO2 (Li
et al. 2003; Seaton and Dennekamp 2003). 
Given this evidence and our findings for
NO2, it is paradoxical that we did not find
FEV1 to be associated with particulate EC or
OC in either personal or ambient samples,
except, in subjects not using bronchodilators,
associations of personal OC with morning and
afternoon FEV1 and personal EC with morn-
ing FEV1. The carbon fraction of PM is
derived primarily from products of fossil fuel
combustion, so EC and OC should be reason-
ably good surrogates for causal pollutant com-
ponents derived from those sources. In our
previous report using exhaled NO, we found
associations with personal and ambient NO2
were largely independent of associations with
personal and ambient EC and OC fractions of
PM2.5 in two-pollutant models, thus suggest-
ing different causal pollutant components
(Delfino et al. 2006). It is conceivable that
volatile and semivolatile organic compounds
are behind these findings given their traffic-
related sources and role in particle formation
(Biswas et al. 2007; Schauer and Cass 2000).
Our results for personal PM2.5 are consis-
tent with recent studies showing inverse asso-
ciations of personal and/or ambient PM mass
with FEV1 among schoolchildren with
asthma (Aekplakorn et al. 2003; Delﬁno et al.
2004; Lewis et al. 2005; Trenga et al. 2006).
Magnitudes of association could not be com-
pared, though, because of differences in both
the expression of lung function effect esti-
mates and PM measurement methods.
Investigators of a recent Denver panel study
failed to show associations of ambient PM10
with FEV1 in schoolchildren with persistent
asthma (Rabinovitch et al. 2004), but later
showed that urinary leukotriene E4 and rescue
inhaler use during school hours were posi-
tively associated with morning average and
peak PM2.5 (Rabinovitch et al. 2006).
Few studies of lung function in children
with asthma have used personal particulate air
pollution measurements, and fewer still have
used real-time personal measurements that
allow the assessment of effects of peak particle
exposures (Delfino et al. 2004, 2006). We
previously followed for 2 weeks per subject a
panel of 19 children, 9–17 years of age, with
persistent asthma in San Diego County
(Delﬁno et al. 2004). We found that FEV1 sig-
niﬁcantly decreased similarly in relation to both
24-hr personal PM and 1-hr maximum per-
sonal PM, but FEV1 was not associated with
outdoor ambient PM2.5 In the present study,
we found that personal hourly peak was a
stronger and more signiﬁcant predictor of FEV1
compared with 24-hr average personal PM2.5.
The present associations of FEV1 with
hourly PM2.5 in the distributed lag models
suggest that inverse associations were primarily
from exposure ≥ 8 hr before the lung function
measurement. PM2.5 concentrations peaked in
mid-morning and they were sustained for sev-
eral hours into the afternoon and evening
(Figure 1). Particles from morning rush hour
traffic and in-vehicle exposures followed by
secondary photochemical particle formation
would have occurred throughout the late
morning and afternoon, including time in
school. Although this was possibly important
in our findings, the resolution of the hourly
PM2.5 data is limited primarily by the fact that
we used ﬁne particle mass rather than compo-
sition or other particle size fractions. 
We previously conducted distributed lag
analyses of hourly personal PM2.5 using the pre-
sent panel and showed that exhaled NO (col-
lected in the late afternoon to early evening)
was positively associated with PM2.5 in the 5 hr
before measurement (Delﬁno et al. 2006). 
Conclusions. The associations we found
between personal NO2 and FEV1 deﬁcits may
be attributable to other more toxic pollutants
from trafﬁc-related sources. Largely indepen-
dent associations between personal PM2.5 and
FEV1 deﬁcits suggest a subset of causal compo-
nents different from personal NO2. We further
conclude that associations of lung function
with particulate air pollutants might be missed
using ambient central-site data alone unless a
large number of repeated observations per per-
son are available. Our results may also not be
generalizable to situations where central-site
measurements are more representative of per-
sonal exposures in other geographic locations.
Future work should focus on identifying causal
pollutant components and their sources. This
will require detailed assessments of exposure
close to where children at risk live and attend
school—a task not possible using available
criteria air pollutant data.
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